Jefferies Downgrades Hologic (HOLX) to Hold
More News related to HOLX
- Hologic (HOLX) volatility Elevated at 85 into Radiology exhibition
- Hologic, Inc. to Host Investor Reception at the RSNA Trade Show
- Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
- Morning Movers 11/12: Best Buy (BBY) Sinks On Lower Guidance; GM (GM) Up On Bailout Hope
- After-Hours Movers 11/11: Intrepid Potash (IPI) Down On Results, Cephalon (CEPH) Up on S&P 500 Add
More News related to Downgrades
- China Sky One Medical, Inc. Interviewed in The China Perspective
- Sony Unveils Another World First: The BRAVIA-drome
- Science|Business Innovation Board Announces the Winners of the First Pan-European Awards For Academic Enterprise
- Pharmalicensing and Panel Intelligence Enter into Strategic Alliance
- Discover These Interesting Threads of Life -- Veteran Writer's New Book Offers Readers an Introspective and Whimsical Look at Her Life
Jefferies downgrades Hologic (Nasdaq: HOLX) from Buy to Hold.
Hologic, Inc. operates as a diversified medical technologies company.
Related Categories
DowngradesStocks Mentioned
-1.11Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
